Enhancer of Zeste Homologue 2 (EZH2) may relate to progression of intra and extrahepatic cholangiocarcinoma

被引：0

作者：

Nakagawa, Shigeki ^{[1
]}

Okabe, Hlrohisa ^{[1
]}

Beppu, Toru ^{[1
]}

Kuroki, Hideyuki ^{[1
]}

Mima, Kousuke ^{[1
]}

Hayashi, Hiromitu ^{[1
]}

Imai, Katsunori ^{[1
]}

Nitta, Hidetoshi ^{[1
]}

Nakahara, Osamu ^{[1
]}

Ikuta, Yoshiaki ^{[1
]}

Chikamoto, Akira ^{[1
]}

Ishiko, Takatoshi ^{[1
]}

Takamori, Hiroshi ^{[1
]}

Baba, Hideo ^{[1
]}

机构：

[1] Kumamoto Univ, Grad Sch Med Sci, Kumamoto, Japan

来源：

CANCER RESEARCH | 2012年 / 72卷

关键词：

D O I：

10.1158/1538-7445.AM2012-1055

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1055

引用

页数：2

共 50 条

[21] 18F-Labeled PET Probe Targeting Enhancer of Zeste Homologue 2 (EZH2) for Cancer Imaging
Yu, Lihai
Despotovic, Nikola
Kovacs, Michael S.
Pin, Christopher L.
Luyt, Leonard G.
ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (03): : 334 - 340
[22] Epigenetic Control of Osteoblast Differentiation by Enhancer of Zeste Homolog 2 (EZH2)
Amel Dudakovic
Andre J. van Wijnen
Current Molecular Biology Reports, 2017, 3 (2) : 94 - 106
[23] Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (EZH2)
Xu, Xin
Chen, Jia
Wang, Guan
Zhang, Xiaojuan
Li, Qiang
Zhou, Xiaobo
Guo, Fengying
Li, Min
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 97
[24] Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cells
Boehm, Julian
Muenzner, Julienne Kathrin
Caliskan, Aylin
Ndreshkjana, Benardina
Erlenbach-Wuensch, Katharina
Merkel, Susanne
Croner, Roland
Rau, Tilman T.
Geppert, Carol Immanuel
Hartmann, Arndt
Roehe, Adriana Vial
Schneider-Stock, Regine
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (09) : 2227 - 2240
[25] Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cells
Julian Böhm
Julienne Kathrin Muenzner
Aylin Caliskan
Benardina Ndreshkjana
Katharina Erlenbach-Wünsch
Susanne Merkel
Roland Croner
Tilman T. Rau
Carol Immanuel Geppert
Arndt Hartmann
Adriana Vial Roehe
Regine Schneider-Stock
Journal of Cancer Research and Clinical Oncology, 2019, 145 : 2227 - 2240
[26] Value of Enhancer of Zeste Homolog 2 (EZH2) for Determining Prognosis in Colon Cancer
Gholami, Nassrin
Sanaat, Zohreh
Dolatkhah, Roya
Nikanfar, Alireza
Esfahani, Ali
Danandehmehr, Amin
Akhrjou, Ashraf
Farassati, Faris
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2020, 14 (03)
[27] Association of Enhancer of Zeste 2 (EZH2) Genotypes with Bladder Cancer Risk in Taiwan
Chang, Wen-Shin
Liao, Cheng-Hsi
Tsai, Chia-Wen
Hu, Pei-Shin
Wu, Hsi-Chin
Hsu, Shih-Wei
Hsiao, Chieh-Lun
Hsu, Chang-Hsien
Hung, Yi-Wen
Bau, Da-Tian
ANTICANCER RESEARCH, 2016, 36 (09) : 4509 - 4514
[28] Expression of Enhancer of Zeste Homolog 2 (EZH2) in Invasive Neuroendocrine Carcinoma of the Breast
Gong, Y.
Chen, J.
Wang, J.
Radvanyi, L.
Rosen, D. G.
Wu, Y.
MODERN PATHOLOGY, 2013, 26 : 44A - 45A
[29] Enhancer of zeste homolog 2 (Ezh2) controls bone formation and cell cycle progression during osteogenesis in mice
Dudakovic, Amel
Camilleri, Emily T.
Paradise, Christopher R.
Samsonraj, Rebekah M.
Gluscevic, Martina
Paggi, Carlo Alberto
Begun, Dana L.
Khani, Farzaneh
Pichurin, Oksana
Ahmed, Farah S.
Elsayed, Ranya
Elsalanty, Mohammed
McGee-Lawrence, Meghan E.
Karperien, Marcel
Riester, Scott M.
Thaler, Roman
Westendorf, Jennifer J.
van Wijnen, Andre J.
JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (33) : 12894 - 12907
[30] Expression of Enhancer of Zeste Homolog 2 (EZH2) in Invasive Neuroendocrine Carcinoma of the Breast
Gong, Y.
Chen, J.
Wang, J.
Radvanyi, L.
Rosen, D. G.
Wu, Y.
LABORATORY INVESTIGATION, 2013, 93 : 44A - 45A

← 1 2 3 4 5 →